| 1 |
Sung H，Ferlay J，Siegel RL，et al.Global Cancer Statistics 2020：GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]．CA Cancer J Clin，2021，71(3)：209-249.
|
| 2 |
Siegel RL，Miller KD，Jemal A．Cancer Statistics，2017[J]．CA Cancer J Clin，2017，67(1)：7-30.
|
| 3 |
Chen W，Zheng R，Baade PD，et al.Cancer statistics in China，2015[J]．CA Cancer J Clin，2016，66(2)：115-132.
|
| 4 |
Karimi P，Islami F，Anandasabapathy S，et al.Gastric cancer：descriptive epidemiology，risk factors，screening，and prevention[J]．Cancer Epidemiol Biomarkers Prev，2014，23(5)：700-713.
|
| 5 |
Snyth EC，Nilsson M，Grabsch HI，et al.Gastric cancer[J]．Lancet，2020，396(10251)：635-648.
|
| 6 |
Wei L，Sun J，Zhang N，et al.Noncoding RNAs in gastric cancer：implications for drug resistance[J]．Mol Cancer，2020，19(1)：62.
|
| 7 |
Biagioni A，Skalamera I，Peri S，et al.Update on gastric cancer treatments and gene therapies[J]．Cancer Metastasis Rev，2019，38(3)：537-548.
|
| 8 |
Pegtel DM，Gould SJ.Exosomes[J]．Annu Rev Biochem，2019，88：487-514.
|
| 9 |
Xavier CPR，Caires HR，Barbosr MAG，et al.The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance[J]．Cells，2020，9(5)：1141.
|
| 10 |
Wang M，Ji S，Shao G，et al.Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients[J]．Clin Transl Oncol，2018，20(7)：906-911.
|
| 11 |
Wang H，Lu Z，Zhao X．Tumorigenesis，diagnosis，and therapeutic potential of exosomes in liver cancer[J]．J Hematol Oncol，2019，12(1)：133.
|
| 12 |
Huang T，Deng CX.Current Progresses of Exosomes as Cancer Diagnostic and Prognostic Biomarkers[J]．Int J Biol Sci，2019，15(1)：1-11.
|
| 13 |
Kopp F，Mendell JT.Functional Classification and Experimental Dissection of Long Noncoding RNAs[J]．Cell，2018，172(3)：393-407.
|
| 14 |
Bhan A，Soleimani M，Mandal SS.Long Noncoding RNA and Cancer：A New Paradigm[J]．Cancer Res，2017，77(15)：3965-3981.
|
| 15 |
Rathinasamy B，Velmurugan BK.Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals[J]．Biomed Pharmacother，2018，102：242-248.
|
| 16 |
Zheng R，DU M，Wang X，et al.Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression[J]．Mol Cancer，2018，17(1)：143.
|
| 17 |
Chen C，Chen Q，Zhao Q，et al.Value of Combined Detection of Serum CEA，CA72-4，CA19-9，CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer[J]．Ann Clin Lab Sci，2017，47(3)：260-263.
|
| 18 |
Zhao R，Zhang Y，Zhang X，et al.Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer[J]．Mol Cancer，2018，17(1)：68.
|
| 19 |
Lin LY，Yang L，Zeng Q，et al.Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer[J]．Mol Cancer，2018，17(1)：84.
|
| 20 |
Li S，Zhang M，Zhang H，et al.Exosomal long noncoding RNA lnc-GNAQ-6：1 may serve as a diagnostic marker for gastric cancer[J]．Clin Chim Acta，2020，501：252-257.
|
| 21 |
Cai C，Zhang H，Zhu Y，et al.Serum Exosomal Long Noncoding RNA pcsk2-2：1 As A Potential Novel Diagnostic Biomarker For Gastric Cancer[J]．Onco Targets Ther，2019，12：10035-10041.
|
| 22 |
Zhou H，Shen W，Zou H，et al.Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer[J]．J Int Med Res，2020，48(7): 300060520934297.
|
| 23 |
Zheng P，Zhang H，Gao H，et al.Plasma Exosomal Long Noncoding RNA lnc-SLC2A12-10：1 as a Novel Diagnostic Biomarker for Gastric Cancer[J]．Onco Targets Ther，2020，13：4009-4018.
|
| 24 |
Xu H，Zhou J，Tang J，et al.Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer[J]．J Clin Lab Anal，2020，34(8)：e23323.
|
| 25 |
Guo X，Lv X，Ru Y，et al.Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer：A Multiphase Study[J]．JAMA Surg，2020，155(7)：572-579.
|
| 26 |
Cao S，Lin L，Xia X，et al.lncRNA SPRY4-IT1 Regulates Cell Proliferation and Migration by Sponging miR-101-3p and Regulating AMPK Expression in Gastric Cancer[J]．Mol Ther Nucleic Acids，2019，17：455-464.
|
| 27 |
Piao HY，Guo S，Wang Y，et al.Exosome-transmitted lncRNA PCGEM1 promotes invasive and metastasis in gastric cancer by maintaining the stability of SNAI1[J]．Clin Transl Oncol，2021，23(2)：246-256.
|
| 28 |
Xin L，Wu Y，Liu C，et al.Exosome-mediated transfer of lncRNA HCG18 promotes M2 macrophage polarization in gastric cancer[J]．Mol Immunol，2021，140：196-205.
|
| 29 |
Wang L，Bo X，Yi X，et al.Exosome-transferred LINC01559 promotes the progression of gastric cancer via PI3K/AKT signaling pathway[J]．Cell Death Dis，2020，11(9)：723.
|
| 30 |
Jin G，Zhang J，Cao T，et al.Exosome-mediated lncRNA SND1-IT1 from gastric cancer cells enhances malignant transformation of gastric mucosa cells via up-regulating SNAIL1[J]．J Transl Med，2022，20(1)：284.
|
| 31 |
Lu Y，Hou K，Li M，et al.Exosome-Delivered LncHEIH Promotes Gastric Cancer Progression by Upregulating EZH2 and Stimulating Methylation of the GSDME Promoter[J]．Front Cell Dev Biol，2020，8：571297.
|
| 32 |
Piao HY，Guo S，Wang Y，et al.Exosomal Long Non-Coding RNA CEBPA-AS1 Inhibits Tumor Apoptosis and Functions as a Non-Invasive Biomarker for Diagnosis of Gastric Cancer[J]．Onco Targets Ther，2020，13：1365-1374.
|
| 33 |
Wang Y，Jiang R，Zhao H，et al.TTN-AS1 delivered by gastric cancer cell-derived exosome induces gastric cancer progression through in vivo and in vitro studies[J]．Cell Biol Toxicol，2022.
|
| 34 |
Sasako M，Sakuramoto S，Katai H，et al.Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer[J]．J Clin Oncol，2011，29(33)：4387-4393.
|
| 35 |
Wang J，Lv B，Su Y，et al.Exosome-Mediated Transfer of lncRNA HOTTIP Promotes Cisplatin Resistance in Gastric Cancer Cells by Regulating HMGA1/miR-218 Axis[J]．Onco Targets Ther，2019，12：11325-11338.
|
| 36 |
Song Q，Lv X，Ru Y，et al.Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer：A multi-cohort，multi-phase study[J]．EBioMedicine，2022，78：103971.
|